drocamorelin   Click here for help

GtoPdb Ligand ID: 10740

Synonyms: AC01 | HM-01 | HM01
Compound class: Synthetic organic
Comment: Drocamorelin (AC01, formerly HM01) is reported as a brain‐penetrating, orally bioavailable, ghrelin peptidomimetic small-molecule agonist [1]. In preclinical models HM01 stimulates gastrointestinal motility, with effects on gastric inflammation and emptying, that are mediated via central and enteric neurons [2-4]. In the heart drocamorelin acts as a calcium sensitizing inotrope that increases cardiac contractility and force, and for this action it has been proposed for the treatment of chronic heart failure.

The chemical structure of AC01/HM01 was matched to that for the INN drocamorelin, as revealed in WHO INN Proposed List 135 (July 2026).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 44.81
Molecular weight 401.16
XLogP 3.98
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ccc(c(c1Cl)Cl)[C@@H](NC(=O)N([C@@H]1CCN(CC1(C)C)C)C)C
Isomeric SMILES COc1ccc(c(c1Cl)Cl)[C@@H](NC(=O)N([C@@H]1CCN(CC1(C)C)C)C)C
InChI InChI=1S/C19H29Cl2N3O2/c1-12(13-7-8-14(26-6)17(21)16(13)20)22-18(25)24(5)15-9-10-23(4)11-19(15,2)3/h7-8,12,15H,9-11H2,1-6H3,(H,22,25)/t12-,15+/m0/s1
InChI Key WGIAKIIMCPKJQN-SWLSCSKDSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Karasawa H, Pietra C, Giuliano C, Garcia-Rubio S, Xu X, Yakabi S, Taché Y, Wang L. (2014)
New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.
Neurogastroenterol Motil, 26 (12): 1771-82. [PMID:25327342]
2. Naitou K, Mamerto T, Pustovit RV, Rivera LR, Callaghan B, Ringuet MT, Chan A, Pietra C, Furness JB. (2015)
The ghrelin receptor agonist, HM01, activates the innervation of the colon to initiate coordinated propulsive contractions and bowel emptying.
Autonomic Neuroscience: Basic & Clinical, 192: p58-59. DOI: 10.1016/j.autneu.2015.07.018
3. Tu L, Lu Z, Ngan MP, Lam FFY, Giuliano C, Lovati E, Pietra C, Rudd JA. (2020)
The brain-penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion-induced emesis in Suncus murinus (house musk shrew).
Br J Pharmacol, 177 (7): 1635-1650. [PMID:31722444]
4. Yuan PQ, Wu SV, Wang L, Taché Y. (2023)
The ghrelin agonist, HM01 activates central vagal and enteric cholinergic neurons and reverses gastric inflammatory and ileus responses in rats.
Neurogastroenterol Motil, 35 (5): e14561. [PMID:36942655]